Jump to content

RTI-353

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Magic links bot (talk | contribs) at 19:11, 22 May 2017 (Replace magic links with templates per local RfC and MediaWiki RfC). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

RTI-353
Identifiers
  • methyl (1R,2S,3S,5S)-3-(4-ethyl-3-iodophenyl)-8-azabicyclo[3.2.1]octane-2-carboxylate
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H22INO2
Molar mass399.266 g/mol g·mol−1
3D model (JSmol)
  • CCC1=C(C=C(C=C1)[C@H]2C[C@@H]3CC[C@H]([C@H]2C(=O)OC)N3)I
  (verify)

RTI(-4229)-353 is a phenyltropane derived drug which acts as an SSRI.[1][2] Tamagnan et al. also made some phenyltropanes with high activity and selectivity for the SERT (pM affinity).

References

  1. ^ Navarro HA, Xu H, Zhong D, Blough BE, Ross WP, Kuhar MJ, Carroll FI. [(125)I]3beta-(4-ethyl-3-iodophenyl)nortropane-2beta-carboxylic acid methyl ester ([(125)I]EINT): a potent and selective radioligand for the brain serotonin transporter. Synapse. 2001 Sep 1;41(3):241-7. PMID 11418937
  2. ^ [1]